XTLB
Xtl BiopharmaceuticalsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
XTLB Profile
Xtl Biopharmaceuticals Ltd.
A biopharmaceutical company that developing drugs for the treatment of autoimmune diseases
Pharmaceutical
03/09/1993
07/15/2013
NASDAQ Stock Exchange
0
12-31
Depository Receipts (Ordinary Shares)
5 Badner St., Ramat Gan, Israel, 5218102
Engaged in the acquisition and research and development of pharmaceutical products.
Xtl Biopharmaceuticals Ltd. was legally established under the laws of the State of Israel on March 9, 1993. The company is engaged in the acquisition and research and development of pharmaceutical products to meet unmet medical needs. Recently working on the treatment of MM, schizophrenia and hepatitis C. The company researches, develops and sells processor-based non-medicinal and non-invasive home therapy devices for the treatment of a variety of diseases. Treated diseases such as high blood pressure, heart failure, insomnia and mental stress.
